0001192482-21-000642.txt : 20210805 0001192482-21-000642.hdr.sgml : 20210805 20210805172140 ACCESSION NUMBER: 0001192482-21-000642 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20210805 DATE AS OF CHANGE: 20210805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOCH KENNETH I CENTRAL INDEX KEY: 0001070009 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37526 FILM NUMBER: 211149584 MAIL ADDRESS: STREET 1: 68 WILLOW AVE CITY: LARCHMONT STATE: NY ZIP: 10538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001621443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260389433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 BUSINESS PHONE: 484-581-7505 MAIL ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 FORMER COMPANY: FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc. DATE OF NAME CHANGE: 20141003 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-03 0001621443 Zynerba Pharmaceuticals, Inc. ZYNE 0001070009 MOCH KENNETH I C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE, SUITE 300 DEVON PA 19333 1 0 0 0 Common Stock 2021-08-03 4 A 0 5000 0 A 5000 D Stock Option (right to buy) 4.44 2021-08-03 4 A 0 7500 0 A 2031-08-03 Common Stock 7500 7500 D The restricted stock award vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders. The option vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders. /s/ Suzanne M. Hanlon, Attorney-in-Fact 2021-08-05